labcorp america lh
take mgmtdiagnos volume dynam
cut guid lcd volum challeng cro intact spoke
lh ceo cfo morn lh announc lower
ep guidanc vs prior larg predic
weaker-than-expect experi core lcd lower lcd
revenu guidanc impli growth vs prior estimate
notabl sequenti slowdown lower requisit growth covanc remain
bright spot rev lh continu experi healthi
revenu growth support robust industri fundamentals/rfp flow
reaffirm prior expect segment howev high level
guid call modest ep growth also disappoint
intra-quart updat reduc ep
tp move
lower view note aggress share repurchas activ
beyond current expect particularli pullback could offer
lab volum lower seemingli transient dynam order
magnitud temper lcd expect driven
weather ca fire slower growth unexpect
previou expect sequenti acceler attribut part
black friday/cyb monday sluggish area lh
nimbl scale back staf headwind persist declin associ
unitedhealthcar contract renew certain doctor preemptiv shift
provid ahead exclus expir area less
concern given volum would nevertheless lost note recent
ar reserv headwind note compon
guidanc updat seemingli company-specif issu
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
labcorp provid diagnost test inform servic
better fundament perform sentiment could drive upsid
target price blue sky scenario lh
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
lh
labcorp america lh
price rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
labcorp america lh
reiter outperform lt driver intact continu view multipl avenu
growth across lh diversifi platform despit aforement headwind core
lcd strong cf gener offer capit deploy flexibl particularli relev
given role lead consolid smaller lab oper post-pama world
importantli lab limit lh activ pama
headwind fulli bake compani valuat
labcorp america lh
compani mention price
labcorp america lh outperform tp
